These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2606279)

  • 1. Clinical impact of H+, K+-ATP-ase inhibitors. Proceedings of a symposium. Maastricht, November 25, 1988.
    Digestion; 1989; 44 Suppl 1():1-95. PubMed ID: 2606279
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the International Symposium on Omeprazole. Monte-Carlo, Monaco, 11-12 November 1988.
    Scand J Gastroenterol Suppl; 1989; 166():1-184. PubMed ID: 2602910
    [No Abstract]   [Full Text] [Related]  

  • 3. Omeprazole and acid inhibition: the essential issues. Proceedings of a symposium. London, April 1990.
    Digestion; 1990; 47 Suppl 1():1-84. PubMed ID: 1982661
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole.
    Gazzard BG
    Br J Clin Pract; 1989 Nov; 43(11):408-11. PubMed ID: 2611096
    [No Abstract]   [Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori in routine clinical practice: doubts and uncertainties.
    Cammarota G; Cianci R; Gasbarrini G
    Hepatogastroenterology; 1999; 46(25):312-5. PubMed ID: 10228814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vision and hearing disorders with omeprazole: the facts].
    Labenz J; Stolte M
    Leber Magen Darm; 1995 Jan; 25(1):6-8, 11. PubMed ID: 7877431
    [No Abstract]   [Full Text] [Related]  

  • 7. [New special drugs registered in Austria. Losec (omeprazole)].
    Farr C; Georgieff GS
    Wien Klin Wochenschr; 1991; 103(11):343-8. PubMed ID: 1858386
    [No Abstract]   [Full Text] [Related]  

  • 8. Contemporary issues in gastrointestinal diseases for clinical pharmacists. Proceedings of a symposium. April 22-24, 1988, Panama Beach, Florida.
    DICP; 1989 Oct; 23(10 Suppl):S1-46. PubMed ID: 2573204
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 10. Coprescribing proton pump inhibitors with other medications.
    Garnett WR; Prescott J
    Manag Care Interface; 2000 Sep; 13(9):71-6, 79. PubMed ID: 11142965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The truth of the story. Proceedings of a sucralfate satellite symposium during the Holland Digestive Diseases Week. Amsterdam, 21 - 24 June 1989.
    Scand J Gastroenterol Suppl; 1990; 173():1-38. PubMed ID: 2349454
    [No Abstract]   [Full Text] [Related]  

  • 12. The Dutch contribution to research and clinical experience with omeprazole.
    Lamers CB; Dols DM
    Digestion; 1989; 44 Suppl 1():1-3. PubMed ID: 2606278
    [No Abstract]   [Full Text] [Related]  

  • 13. Sporadic fundic gland polyps: clinico-pathologic features and associated diseases.
    Declich P; Tavani E; Ferrara A; Caruso S; Bellone S
    Pol J Pathol; 2005; 56(3):131-7. PubMed ID: 16334981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-related diseases: improving the treatment options. Symposium proceedings. Vienna, November 1991.
    Digestion; 1992; 51 Suppl 1():1-124. PubMed ID: 1356866
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Harewood G
    N Engl J Med; 1999 Oct; 341(18):1398; author reply 1398-9. PubMed ID: 10577093
    [No Abstract]   [Full Text] [Related]  

  • 16. The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine.
    Dohil R; Newbury RO; Sellers ZM; Deutsch R; Schneider JA
    J Pediatr; 2003 Aug; 143(2):224-30. PubMed ID: 12970638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical issues of paediatric gastroenterology].
    Baranov AA; Shcherbakov PL
    Eksp Klin Gastroenterol; 2008; (1):102-6. PubMed ID: 19145861
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.